Astroglia-microglia cross talk during neurodegeneration in the rat hippocampus

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Batlle, Montserrat ^a   Ferri, Lorenzo ^a,b   Andrade, Carmen ^a   Ortega, Francisco Javier ^a,c   Vidal Taboada, Jose M ^a   Pugliese, Marco ^a,c   Mahy, Nicole ^a   Rodríguez, Manuel J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b CATHOLIC UNIVERSITY   (Italy)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOADIPIC ACID; CD11B ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NEURON SPECIFIC NUCLEAR PROTEIN; PROTEIN S100B; TUMOR NECROSIS FACTOR ALPHA; BETA N ACETYLHEXOSAMINIDASE; N METHYLASPARTIC ACID; S100B PROTEIN, RAT; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN NERVE CELL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DENTATE GYRUS; EXCITOTOXICITY; GLIOSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA2 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPUS; MACROGLIA; MALE; MICROGLIA; NERVE CELL NECROSIS; NERVE DEGENERATION; NONHUMAN; PHENOTYPIC VARIATION; PROTEIN EXPRESSION; RAT; RAT MODEL; ANIMAL; ASTROCYTE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; INJURIES; METABOLISM; NERVE CELL; PATHOLOGY; SECRETION (PROCESS);

RATTUS;

ANIMALS; ASTROCYTES; BETA-N-ACETYLHEXOSAMINIDASES; CELL PROLIFERATION; GENE EXPRESSION; HIPPOCAMPUS; MICROGLIA; N-METHYLASPARTATE; NERVE DEGENERATION; NEURONS; RATS; RECEPTORS, GLUCOCORTICOID; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84929340386     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/102419     Document Type: Article

References (48)

1. K. Helmut, U.-K. Hanisch, M. Noda, and A. Verkhratsky, "Physiology of microglia," Physiological Reviews, vol. 91, no. 2, pp. 461-553, 2011.
2. F. J. Ortega, J. M. Vidal-Taboada, N.Mahy, and M. J. Rodríguez, "Molecular mechanisms of acute brain injury and ensuing neurodegeneration," in Brain Damage - Bridging between Basic Research and Clinics, A. González-Quevedo, Ed., pp. 163-186, InTech, Rijeka, Croatia, 2012.
3. J. Gimeno-Bayón, A. López-López, M. J. Rodríguez, and N. Mahy, "Glucose pathways adaptation supports acquisition of activated microglia phenotype," Journal of Neuroscience Research, vol. 92, no. 6, pp. 723-731, 2014.
4. W.-S. Qu, D.-S. Tian, Z.-B. Guo et al., "Inhibition of EGFR/MAPKsignaling reduces microglial inflammatory response and the associated secondary damage in rats after spinal cord injury," Journal of Neuroinflammation, vol. 9, article 178, 2012.
5. S. Hellwig, A. Heinrich, and K. Biber, "The brain's best friend: microglial neurotoxicity revisited," Frontiers in Cellular Neuroscience, vol. 7, article 71, 2013.
6. S. Prokop, K. R.Miller, and F. L. Heppner, "Microglia actions in Alzheimer's disease," Acta Neuropathologica, vol. 126, no. 4, pp. 461-477, 2013.
7. F. J.Ortega, J. Jolkkonen,N.Mahy, andM. J.Rodríguez, "Glibenclamide enhances neurogenesis and improves long-term functional recovery after transient focal cerebral ischemia," Journal of Cerebral Blood Flow&Metabolism, vol. 33,no. 3, pp. 356-364, 2013.
8. M.Domercq,N.Vázquez-Villoldo, and C.Matute, "Neurotransmitter signaling in the pathophysiology of microglia," Frontiers in Cellular Neuroscience, vol. 7, article 49, 2013.
9. S.-I.Hung, A. C. Chang, I. Kato, andN.-C.A.Chang, "Transient expression of Ym1, a heparin-binding lectin, during developmental hematopoiesis and inflammation," Journal of Leukocyte Biology, vol. 72, no. 1, pp. 72-82, 2002.
10. G. Stoll, S. Jander, and M. Schroeter, "Detrimental and beneficial effects of injury-induced inflammation and cytokine expression in the nervous system," Advances in Experimental Medicine and Biology, vol. 513, pp. 87-113, 2002.
11. B. Liao, W. Zhao, D. R. Beers, J. S. Henkel, and S. H. Appel, "Transformation froma neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS," Experimental Neurology, vol. 237, no. 1, pp. 147-152, 2012.
12. M. J. Rodríguez, M. Martínez-Moreno, F. J. Ortega, and N. Mahy, "Targeting microglial KATP channels to treat neurodegenerative diseases: a mitochondrial issue," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 194546, 13 pages, 2013.
13. N. Tanuma, H. Sakuma, A. Sasaki, and Y. Matsumoto, "Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis," Acta neuropathologica, vol. 112, no. 2, pp. 195-204, 2006.
14. S. F. Sorrells and R. M. Sapolsky, "An inflammatory review of glucocorticoid actions in the CNS," Brain, Behavior, and Immunity, vol. 21, no. 3, pp. 259-272, 2007.
15. A. Sierra, A. Gottfried-Blackmore, T. A. Milner, B. S. McEwen, and K. Bulloch, "Steroid hormone receptor expression and function in microglia," Glia, vol. 56, no. 6, pp. 659-674, 2008.
16. L. J. van Eldik and M. S. Wainwright, "The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain," Restorative Neurology and Neuroscience, vol. 21, no. 3-4, pp. 97-108, 2003.
17. M. M. Edwards and S. R. Robinson, "TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease," Journal of Neural Transmission, vol. 113, no. 11, pp. 1709-1715, 2006.
18. C.Reali, F. Scintu, R. Pillai, R. Donato, F.Michetti, andV. Sogos, "S100α counteracts effects of the neurotoxicant trimethyltin on astrocytes and microglia," Journal of Neuroscience Research, vol. 81, no. 5, pp. 677-686, 2005.
19. F. Tramontina, A. C. Tramontina,D. F. Souza et al., "Glutamate uptake is stimulated by extracellular S100B in hippocampal astrocytes," Cellular and Molecular Neurobiology, vol. 26, no. 1, pp. 81-86, 2006.
20. V. Blais and S. Rivest, "Effects of TNF-α and IFN-α on nitric oxide-induced neurotoxicity in the mouse brain," Journal of Immunology, vol. 172, no. 11, pp. 7043-7052, 2004.
21. G. J. Liu, R. J. Middleton, C. R. Hatty et al., "The 18 kDa translocator protein, microglia and neuroinflammation," Brain Pathology, vol. 24, no. 6, pp. 631-653, 2014.
22. Q. X. Feng,W.Wang, X. Y. Feng et al., "Astrocytic activation in thoracic spinal cord contributes to persistent pain in rat model of chronic pancreatitis," Neuroscience, vol. 167, no. 2, pp. 501-509, 2010.
23. J. A. Filosa, M. T. Nelson, and L. V. G. Bosc, "Activitydependent NFATc3 nuclear accumulation in pericytes from cortical parenchymal microvessels," The American Journal of Physiology - Cell Physiology, vol. 293, no. 6, pp. C1797-C1805, 2007.
24. M. J. Rodríguez, M.Martínez-Sánchez, F. Bernal, and N.Mahy, "Heterogeneity between hippocampal and septal astroglia as a contributing factor to differential in vivo AMPA excitotoxicity," Journal of Neuroscience Research, vol. 77, no. 3, pp. 344-353, 2004.
25. W. Wang, X. Mei, J. Huang et al., "Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain," PLoS ONE, vol. 4, no. 9,Article ID e6973, 2009.
26. R. J. Bridges, C. G. Hatalski, S. N. Shim et al., "Gliotoxic actions of excitatory amino acids," Neuropharmacology, vol. 31, no. 9, pp. 899-907, 1992.
27. K. Sugawara, K. Torigoe, S. Okoyama, K. Negishi, and S. Kato, "Neurotoxic effects of l-α-aminoadipic acid on the carp retina: a long term observation," Neuroscience, vol. 36, no. 1, pp. 155-163, 1990.
28. G. Paxinos and C.Watson,The Rat Brain in Stereotaxic Coordinates, Academic Press, San Diego, Calif, USA, 1986.
29. F. Bernal, J. Saura, J. Ojuel, and N.Mahy, "Differential vulnerability of hippocampus, basal ganglia, and prefrontal cortex to long-term NMDA excitotoxicity," Experimental Neurology, vol. 161, no. 2, pp. 686-695, 2000.
30. M. E. Dailey andM.Waite, "Confocal imaging of microglial cell dynamics in hippocampal slice cultures," Methods: A Companion to Methods in Enzymology, vol. 18, no. 2, pp. 222-230, 1999.
31. M. J. Rodríguez, J. Saura, C. C. Finch, N.Mahy, and E. E. Billett, "Localization of monoamine oxidase A and B in human pancreas, thyroid, and adrenal glands," Journal of Histochemistry and Cytochemistry, vol. 48, no. 1, pp. 147-151, 2000.
32. M. J. Rodríguez, A. Prats, Y. Malpesa et al., "Pattern of injury with a graded excitotoxic insult and ensuing chronic medial septal damage in the rat brain," Journal of Neurotrauma, vol. 26, no. 10, pp. 1823-1834, 2009.
33. I. K. Hwang, Y.-B. Lee, K.-Y. Yoo et al., "Seizure-induced changes of mineralocorticoid and glucocorticoid receptors in the hippocampus in seizure sensitive gerbils," Neuroscience Research, vol. 53, no. 1, pp. 14-24, 2005.
34. M. Andrés, A. Marino, J. M. Macarulla, and M. Trueba, "Characterization of specific corticosterone binding sites in adrenal cortex plasma membrane and their localization by autoradiographic studies," Cellular and Molecular Life Sciences, vol. 53, no. 8, pp. 673-680, 1997.
35. S. J. Bolton and V. H. Perry, "Differential blood-brain barrier breakdown and leucocyte recruitment following excitotoxic lesions in juvenile and adult rats," Experimental Neurology, vol. 154, no. 1, pp. 231-240, 1998.
36. N. Virgili, J. F. Espinosa-Parrilla, P.Mancera et al., "Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis," Journal of Neuroinflammation, vol. 8, article 149, 2011.
37. N. Virgili, P. Mancera, C. Chanvillard et al., "Diazoxide attenuates autoimmune encephalomyelitis andmodulates lymphocyte proliferation and dendritic cell functionality," Journal of Neuroimmune Pharmacology, vol. 9, no. 4, pp. 558-568, 2014.
38. L. de Yebra, Y. Malpesa, G. Ursu et al., "Dissociation between hippocampal neuronal loss, astroglial and microglial reactivity after pharmacologically induced reverse glutamate transport," Neurochemistry International, vol. 49, no. 7, pp. 691-697, 2006.
39. N. Giannetti, E. Moyse, A. Ducray et al., "Accumulation of Ym1/2 protein in the mouse olfactory epithelium during regeneration and aging," Neuroscience, vol. 123, no. 4, pp. 907-917, 2004.
40. M. V. Sofroniew and H. V. Vinters, "Astrocytes: biology and pathology," Acta Neuropathologica, vol. 119, no. 1, pp. 7-35, 2010.
41. A. Suzumura, H. Takeuchi, G. Zhang, R. Kuno, and T. Mizuno, "Roles of glia-derived cytokines on neuronal degeneration and regeneration," Annals of the New York Academy of Sciences, vol. 1088, pp. 219-229, 2006.
42. V. Fontaine, S. Mohand-Said, N. Hanoteau,C. Fuchs,K. Pfizenmaier, and U. Eisel, "Neurodegenerative and neuroprotective effects of tumor Necrosis factor (TNF) in retinal ischemia: opposite roles of TNF receptor 1 and TNF receptor 2," The Journal of Neuroscience, vol. 22, no. 7, Article IDRC216, 2002.
43. L. Bernardino, F. Agasse, B. Silva, R. Ferreira, S. Grade, and J. O. Malva, "Tumor necrosis factor-α modulates survival, proliferation, and neuronal differentiation in neonatal subventricular zone cell cultures," StemCells, vol. 26,no. 9, pp. 2361-2371, 2008.
44. S. Rivest, "Molecular insights on the cerebral innate immune system," Brain, Behavior, and Immunity, vol. 17, no. 1, pp. 13-19, 2003.
45. R. Bianchi, I. Giambanco, and R. Donato, "S100B/RAGEdependent activation of microglia viaNF-kappaB andAP-1.Coregulation of COX-2 expression by S100B, IL-1beta and TNFalpha," Neurobiology of Aging, vol. 31, no. 4, pp. 665-677, 2010.
46. F. J. Ortega, J.Gimeno-Bayon, J. F. Espinosa-Parrilla et al., "ATPdependent potassium channel blockade strengthens microglial neuroprotection after hypoxia-ischemia in rats," Experimental Neurology, vol. 235, no. 1, pp. 282-296, 2012.
47. F. Chrétien, A.-V. Vallat-Decouvelaere, C. Bossuet et al., "Expression of excitatory amino acid transporter-2 (EAAT-2) and glutamine synthetase (GS) in brain macrophages and microglia of SIVmac251-infected macaques," Neuropathology & Applied Neurobiology, vol. 28, no. 5, pp. 410-417, 2002.
48. F. K. H. van Landeghem, J. F. Stover, I. Bechmann et al., "Early expression of glutamate transporter proteins in ramified microglia after controlled cortical impact injury in the rat," Glia, vol. 35, no. 3, pp. 167-179, 2001.